SCHEMBL20104346

SCHEMBL20104346

CC1(C)OB(c2nc(-c3ccccc3)c3ccccc3n2)OC1(C)C

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NUDT1 P36639 3/20 0.46
▸ ADORA2A P29274 5/20 0.46
▸ LPL P06858 1/20 0.46
▸ LIPG Q9Y5X9 1/20 0.46
▸ MAPT P10636 4/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ GAA P10253 2/20 0.43
▸ ALDH1A1 P00352 5/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ HPGD P15428 3/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ ATM Q13315 1/20 0.41
▸ LMNA P02545 3/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ RAD52 P43351 1/20 0.40
▸ GLA P06280 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21709413 0.97 LPL (0.51) NUDT1ADORA2ALPLLIPGMAPT
SCHEMBL28523446 0.82 ALDH1A1 (0.46) NUDT1ADORA2AMAPTMEN1KMT2A
SCHEMBL27360056 0.81 MEN1 (0.45) NUDT1ADORA2ALPLLIPGMAPT
SCHEMBL31644060 0.79 LIPG (0.59) NUDT1ADORA2ALPLLIPGMEN1
SCHEMBL19106654 0.79 LIPG (0.59) NUDT1ADORA2ALPLLIPGMEN1
SCHEMBL17412355 0.79 LIPG (0.59) NUDT1ADORA2ALPLLIPGMEN1
SCHEMBL23352767 0.78 LIPG (0.61) NUDT1ADORA2ALPLLIPGMEN1
SCHEMBL19106647 0.78 LIPG (0.61) NUDT1ADORA2ALPLLIPGMEN1
SCHEMBL31683834 0.78 LIPG (0.61) NUDT1ADORA2ALPLLIPGMEN1
SCHEMBL19106655 0.78 LIPG (0.61) NUDT1ADORA2ALPLLIPGMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12415949-B2 Compound, organic electroluminescent device, and display device SK INC. (KR) 2025-09-16 — — US disclosed
US-11472800-B2 Organic compound and organic electroluminescent device comprising the same DOOSAN SOLUS CO., LTD. (KR) 2022-10-18 — — US disclosed
CN-114014851-A Fluorene structural compound and application thereof 北京燕化集联光电技术有限公司 2022-02-08 — — CN disclosed
CN-113861210-A Compound containing spiro furocarbazole structure and application thereof 北京云基科技有限公司 2021-12-31 — — CN disclosed
CN-113563349-A Spiro pyrrolocarbazole compound, application thereof and organic electroluminescent device using same 北京云基科技有限公司 2021-10-29 — — CN disclosed
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE SK MATERIALS CO., LTD. (KR) 2021-05-13 — — US disclosed
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE SK MATERIALS CO., LTD. (KR) 2021-05-13 — — US disclosed
WO-2021020799-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRIC ELEMENT 덕산네오룩스 주식회사 2021-02-04 — — WO disclosed
CN-112262144-A Compound, organic electroluminescent device and display device SK材料有限公司 2021-01-22 — — CN disclosed
US-20200048207-A1 COMPOUNDS WITH ARYLAMINE STRUCTURES MERCK PATENT GMBH (DE) 2020-02-13 — — US disclosed
US-20190263806-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DOOSAN CORPORATION (KR) 2019-08-29 — — US disclosed
US-20190263806-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DOOSAN CORPORATION (KR) 2019-08-29 — — US disclosed
WO-2018080065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME 주식회사 두산 2018-05-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12415949-B2 Compound, organic electroluminescent device, and display device L1CAM, EML4, OCIAD2 NUDT1 603/4885ADORA2A 2070/4885LPL 159/4885
US-11472800-B2 Organic compound and organic electroluminescent device comprising the same VDAC1, OR10J3, VDAC2 NUDT1 708/4885ADORA2A 4400/4885LPL 1261/4885
US-20200048207-A1 COMPOUNDS WITH ARYLAMINE STRUCTURES DDT, NAT1, INMT NUDT1 15/4885ADORA2A 319/4885LPL 4565/4885
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE L1CAM, EML4, OCIAD2 NUDT1 603/4885ADORA2A 2070/4885LPL 159/4885
US-20190263806-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME VDAC1, OR10J3, VDAC2 NUDT1 708/4885ADORA2A 4400/4885LPL 1261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback